An interventional study of Use of phentolamine eye drops to reverse cycloplegia and Pilocarpine 0.1% in Pupillary Constriction and Accomodation, sponsored by Mansoura University. Not yet recruiting. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-06-10.
Sponsored by Mansoura University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The study aims at reversing pupillary dilatation. and cycloplegia in children undergoing cycloplegic refraction for eyeglasses prescription and ocular examination. This will be achieved using pilocarpine , phentolamine or a combination. This may help decrease the glare and improve near vision early to decrease unwanted effects of cycloplegic drops.
To compare the efficacy of pilocarpine 0.1%, phentolamine 0.75%, and combined therapy in reversing cyclopentolate-induced cycloplegia/mydriasis in pediatric patients using a within-subject paired-eye design (treated vs. untreated eye).
Interventions
Cycloplegia Induction:
Both eyes receive cyclopentolate 1% (2 drops, 5 minutes apart). Then cycloplegic effect confirmed at 30 minutes (accommodation ≤2 D, pupil ≥6 mm).
Reversal Agents (administered at 30 minutes post-cyclopentolate):
Pilocarpine group: Pilocarpine 0.1% (1 drop) in the study eye; placebo in the control eye.
Phentolamine group: Phentolamine 0.75% (1 drop) in the study eye; placebo in the control eye.
Combination: Pilocarpine 0.1% + phentolamine 0.75% (1 drop each) in the study eye; placebo in the control eye.
Mansoura University is the lead sponsor of 1,120 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children will receive pilocarpine drops in one eye and placebo in the other
Drug: Pilocarpine 0.1%
Children will receive phentolamine eye drop in one eye and placebo in the other
Drug: Use of phentolamine eye drops to reverse cycloplegia
Children will receive a combination of pilocarpine and placebo in one eye and placebo in the other
Drug: Combination of pilocarpine 0.1% and phentolamine 0.75%
Use of phentolamine 0.75% eye drops to reverse cycloplegia
Use of pilocarpine 0.1% to reverse cycloplegia
Drug pages: Pilocarpine · Phentolamine
Combination of pilocarpine 0.1% and phentolamine 0.75%
Reversal of pupillary dilatation
Time frame: Hourly for four hours after administration of the drug
Recovery of accommodation after instillation of the drop
Time frame: Hourly for four hours after administration of the drug
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2025; primary completion for Dec 2025, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Pilocarpine · Phentolamine
Miosis